Department of Defense.
Notice of meeting.
Pursuant to the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix as amended), the Sunshine in the Government Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, and in accordance with section 10(a)(2) of Public Law, the following meeting of the Defense Health Board (DHB) is announced:
May 7-8, 2009.
May 7, 2009.
7 a.m.-12 p.m. (Open Session).
12 p.m.-2:15 p.m. (Administrative Working Meeting).
2:15 p.m.-5:15 p.m. (Open Session).
May 8, 2009.
8 a.m.-2 p.m. (Closed Session).
May 7, 2009, Ballroom, Sheraton Chrystal City Hotel, 1800 Jefferson Davis Highway Arlington, VA 22202.
May 8, 2009 Industrial College of the Armed Forces, Fort McNair, Washington, DC.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Commander Edmond F. Feeks, Executive Secretary, Defense Health Board, Five Skyline Place, 5111 Leesburg Pike, Suite 810, Falls Church, Virginia 22041-3206, (703) 681-8448, EXT. 1228, Fax: (703)-681-3317, firstname.lastname@example.org. Additional information, agenda updates, and meeting registration are available online at the Defense Health Board Web site, http://www.ha.osd.mil/dhb. The public is encouraged to register for the meeting. If special accommodations are required to attend (sign language, wheelchair accessibility) please contact Ms. Lisa Jarrett at (703) 681-8448 ext. 1280 by April 30, 2009. Written statements may be mailed to the above address, emailed to email@example.com or faxed to (703) 681-3317.End Further Info End Preamble Start Supplemental Information
Purpose of the Meeting: The purpose of the meeting is to address and deliberate pending and new Board issues and provide briefings for Board members on topics related to ongoing Board business.
Agenda: On May 7, 2009, the Board will receive a briefing on Iraqi Health Start Printed Page 18698Sector Reconstruction. The following Defense Health Board Subcommittees will present updates to the Board: the Millennium Cohort Study, the Psychological Health External Advisory Subcommittee, the Trauma and Injury Subcommittee, the Vaccine Safety and Effectiveness Report, the National Capital Region Base Realignment and Closure Subcommittee, and the Traumatic Brain Injury External Advisory Subcommittee. The Board will also receive an informational briefing on the use of the Warren Cohort Serum Repository.
Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR102-3.155, in the interest of national security, the Department of Defense has determined that the meeting on May 8, 2009 will be closed to the public. The Under Secretary of Defense (Personnel and Readiness), in consultation with the Office of the DoD General Counsel, has determined in writing that the public interest requires that the session on May 8, 2009 be closed to public because they will concern matters listed in section 552b(c)(1) of title 5, United States Code. Specifically the information presented meets criteria established by an executive order to be kept secret in the interest of national defense and foreign policy.
Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102-3.140 through 102-3.165 and subject availability of space, the Defense Health Board meeting from 7 a.m. to 12 p.m. and from 2:15 p.m. to 5:15 p.m. on May 7, 2009 is open to the public. Any member of the public wishing to provide input to the Defense Health Board should submit a written statement in accordance with 41 CFR 102-3.140(C) and section 10(a)(3) of the Federal Advisory Committee Act, and the procedures described in this notice. Written statement should be not longer than two type-written pages and must address the following detail: The issue, discussion, and a recommended course of action. Supporting documentation may also be included as needed to establish the appropriate historical context and to provide any necessary background information.
Individuals desiring to submit a written statement may do so through the Board's Designated Federal Officer at the address detailed above at any point. However, if the written statement is not received at least 10 calendar days prior to the meeting, which is subject to this notice, then it may not be provided to or considered by the Defense Health Board until the next open meeting.
The Designated Federal Officer will review all timely submissions with the Defense Health Board Chairperson, and ensure they are provided to members of the Defense Health Board before the meeting that is subject to this notice. After reviewing the written comments, the Chairperson and the Designated Federal Officer may choose to invite the submitter of the comments to orally present their issue during an open portion of this meeting or at a future meeting.
The Designated Federal Officer, in consultation with the Defense Health Board Chairperson, may, if desired, allot a specific amount of time for members of the public to present their issues for review and discussion by the Defense Health Board.Start Signature
Dated: April 20, 2009.
Morgan E. Frazier,
Alternate OSD Federal Register, Liaison Officer, Department of Defense.
[FR Doc. E9-9390 Filed 4-23-09; 8:45 am]
BILLING CODE 5001-06-P